Atlas Trials

Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"

Clinical trial NCT03555578 · COMPLETED

Trial details

NCT number
NCT03555578
Sponsor
Takeda
Status
COMPLETED
Study type
OBSERVATIONAL
Spinal and Bulbar Muscular Atrophy
Start date
2017-11-02
Primary completion
2026-04-30
Enrollment
1905

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.